Harrow, Inc.
HROW
#5881
Rank
NZ$2.08 B
Marketcap
NZ$55.59
Share price
-5.35%
Change (1 day)
-19.78%
Change (1 year)

Earnings for Harrow, Inc. (HROW)

Earnings in 2026 (TTM): -NZ$18.67 Million

According to Harrow, Inc.'s latest financial reports the company's current earnings are NZ$0.27 Billion. In 2025 the company made an earning of NZ$41.7 Million, an increase over its 2024 earnings that were of NZ$9.99 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Harrow, Inc. from 2007 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$18.67 Million-144.77%
2025 NZ$41.7 M317.34%
2024 NZ$9.99 M-329.09%
2023 -NZ$4.37 Million-224.34%
2022 NZ$3.5 M3.01%
2021 NZ$3.4 M149.06%
2020 NZ$1.36 M434.29%
2019 NZ$0.25 M-102.68%
2018 -NZ$9.54 Million-57.11%
2017 -NZ$22.24 Million-21.93%
2016 -NZ$28.48 Million5.11%
2015 -NZ$27.1 Million46.16%
2014 -NZ$18.54 Million32.68%
2013 -NZ$13.98 Million42.63%
2012 -NZ$9.8 Million
2010 -NZ$4.53 Million-45.76%
2009 -NZ$8.35 Million21.83%
2008 -NZ$6.85 Million-491.97%
2007 NZ$1.74 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-NZ$0.3 Billion 1,423.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-NZ$33.19 Million 73.81%๐Ÿ‡บ๐Ÿ‡ธ USA